{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T18:04:02Z","timestamp":1759514642163,"version":"3.32.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1996,7,1]],"date-time":"1996-07-01T00:00:00Z","timestamp":836179200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Osteoporosis Int"],"published-print":{"date-parts":[[1996,7]]},"DOI":"10.1007\/bf01623388","type":"journal-article","created":{"date-parts":[[2005,4,30]],"date-time":"2005-04-30T21:45:30Z","timestamp":1114897530000},"page":"297-302","source":"Crossref","is-referenced-by-count":19,"title":["New biochemical markers of bone resorption derived from collagen breakdown in the study of postmenopausal osteoporosis"],"prefix":"10.1007","volume":"6","author":[{"given":"R.","family":"Guerrero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Diaz Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. M.","family":"Diaz Diego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Turbi","family":"Disla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rapado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"de la Piedra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1002\/jbmr.5650080515","volume":"8","author":"SM Seyedin","year":"1993","unstructured":"Seyedin SM, Kung VT, Daniloff YN, et al. Immunoassay for urinary pyridinoline: the new marker of bone resorption. J Bone Miner Res 1993;8:635\u201341.","journal-title":"J Bone Miner Res"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/jbmr.5650091019","volume":"9","author":"SP Robins","year":"1994","unstructured":"Robins SP, Woitge H, Hesley R, Ju J, Seyedin S, Seibel MJ. Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption. J Bone Miner Res 1994;9:1643\u20139.","journal-title":"J Bone Miner Res"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/clinchem\/39.4.635","volume":"39","author":"J Risteli","year":"1993","unstructured":"Risteli J, Elomaa I, Niemi S, Novamo A, Risteli L. Radioimmunoassay for the pyridinoline cross-linked carboxyterminal telopeptides of type I collagen: a new serum marker of bone collagen degradation. Clin Chem 1993;39:635\u201340.","journal-title":"Clin Chem"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/jbmr.5650071119","volume":"7","author":"DA Hanson","year":"1992","unstructured":"Hanson DA, Weis MAE, Bollen AM, Maslan SL, Singer FR, Eyre DR. A specific immunoassay for monitoring human bone resorption: quantitation of type I collagen cross-linked N-telopeptides in urine. J Bone Miner Res 1992;7:1251\u20138.","journal-title":"J Bone Miner Res"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1093\/clinchem\/40.11.2022","volume":"40","author":"M Bonde","year":"1994","unstructured":"Bonde M, Qvist P, Fledelins C, Riis BJ, Christiansen C. Immunoassay for quantifying type I collagen degradation products in urine evaluated. Clin Chem 1994;40:2024\u20135.","journal-title":"Clin Chem"},{"issue":"Suppl 2","key":"CR6","doi-asserted-by":"crossref","first-page":"S549","DOI":"10.1002\/jbmr.5650081323","volume":"8","author":"PD Delmas","year":"1993","unstructured":"Delmas PD. Biochemical markers of bone turnover. J Bone Miner Res 1993;8 (Suppl 2):S549\u201355.","journal-title":"J Bone Miner Res"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0003-2697(67)90160-1","volume":"19","author":"KI Kivirikko","year":"1967","unstructured":"Kivirikko KI, Laitinen O, Procop OJ. Modifications of a specific assay for hydroxyproline in urine. Anal Biochem 1967;19:249\u201355.","journal-title":"Anal Biochem"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/clinchem\/39.4.561","volume":"39","author":"MH Zweig","year":"1993","unstructured":"Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993;39:561\u201377.","journal-title":"Clin Chem"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1210\/jcem.74.3.1740477","volume":"74","author":"D Eyre","year":"1992","unstructured":"Eyre D. Editorial. New biomarkers of bone resorption. J Clin Endocrinol Metab 1992;74:470A-B.","journal-title":"New biomarkers of bone resorption. J Clin Endocrinol Metab"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-6009(08)80076-1","volume":"22","author":"NA Hamdy","year":"1993","unstructured":"Hamdy NA, Papapoulos SE, Colwell A, Eastell R, Russell RG. Urinary collagen crosslink excretion: a better index of bone resorption than hydroxyproline in Paget's disease of bone? Bone Miner 1993;22:1\u20138.","journal-title":"Bone Miner"},{"key":"CR11","first-page":"1","volume":"Suppl 2","author":"A Rapado","year":"1988","unstructured":"Rapado A, De la Piedra C, Torres R. BGP (osteocalcin, bone Gla protein) in involutional osteoporosis. Clin Rheumatol 1988;Suppl 2:1\u20135.","journal-title":"Clin Rheumatol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1042\/bj1970759","volume":"197","author":"Z Gunja-Smith","year":"1981","unstructured":"Gunja-Smith Z, Boucek R. Collagen cross-linking compounds in human urine. Biochem J 1981;197:759\u201362.","journal-title":"Biochem J"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/1043-2760(92)90129-O","volume":"3","author":"MJ Seibel","year":"1992","unstructured":"Seibel MJ, Robins SP, Bilezikian JP. Urinary pyridinium crosslinks of collagen. Trends Endocrinol Metab 1992;3:263\u201370.","journal-title":"Trends Endocrinol Metab"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0169-6009(91)90143-N","volume":"8","author":"D Uebelhart","year":"1990","unstructured":"Uebelhart D, Gineyts E, Chapuy MC, Delmas PH. Urinary excretion of pyridinium cross-links: a new marker of bone resorption in metabolic bone disease. Bone Miner 1990;8:87\u201396.","journal-title":"Bone Miner"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF00305523","volume":"54","author":"C Fledelius","year":"1994","unstructured":"Fledelius C, Riis BJ, Overgaard K, Christiansen C. The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis. Calcif Tissue Int 1994;54:381\u20134.","journal-title":"Calcif Tissue Int"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1365-2362.1992.tb01444.x","volume":"22","author":"PA Mole","year":"1992","unstructured":"Mole PA, Walkinshaw MH, Robins SP, et al. Can urinary pyridinium crosslinks and urinary oestrogens predict bone mass and rate of bone loss after the menopause? Eur J Clin Invest 1992;22:767\u201371.","journal-title":"Eur J Clin Invest"},{"key":"CR17","first-page":"279","volume":"16","author":"MJ Seibel","year":"1991","unstructured":"Seibel MJ, Ratcliffe A, Cosman F. Urinary hydroxypyridinium crosslinks of collagen are markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. Trans Orthop Res Soc 1991;16:279\u201381.","journal-title":"Trans Orthop Res Soc"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/ard.51.5.648","volume":"51","author":"AM McLaren","year":"1992","unstructured":"McLaren AM, Hordon LD, Bird HA, et al. Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture. Ann Rheum Dis 1992;51:648\u201351.","journal-title":"Ann Rheum Dis"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1210\/jcem-72-2-367","volume":"72","author":"D Uebelhart","year":"1991","unstructured":"Uebelhart D, Schlemmer A, Johansen JS, Gineyts E, Christiansen C, Delmas PD. Effect of menopause and hormone replacement therapy on the urinary excretion of pyridinium crosslinks. J Clin Endocrinol Metab 1991;72:367\u201373.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF01623829","volume":"3","author":"R Eastell","year":"1993","unstructured":"Eastell R, Robins SP, Colwell T, Assiri AMA, Riggs BL, Russell RGG. Evaluation of bone turnover in type I osteoporosis using biochemical markers specific for both bone formation and bone resorption. Osteoporosis Int 1993;3:255\u201360.","journal-title":"Osteoporosis Int"},{"key":"CR21","first-page":"864","volume":"80","author":"M Bonde","year":"1995","unstructured":"Bonde M, Qvist P, Fledelius C, Riis BJ, Christiansen C. Applications of an enzyme immunoassay for a new marker of bone resorption (Cross-Laps): follow-up on hormone replacement therapy and osteoporosis risk assessment. J Clin Endocrinol Metab 1995;80:864\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/BF00316286","volume":"54","author":"C Hassager","year":"1994","unstructured":"Hassager C, Jensen LT, Podenphant J, Thomsen K, Christiansen C. The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy. Calcif Tissue Int 1994;54:30\u20133.","journal-title":"Calcif Tissue Int"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-6009(08)80147-X","volume":"24","author":"P Charles","year":"1994","unstructured":"Charles P, Mosekilde L, Risteli L, Risteli J, Eriksen EF. Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. Bone Miner 1994;24:81\u201394.","journal-title":"Bone Miner"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1002\/jbmr.5650090907","volume":"9","author":"M Kassem","year":"1994","unstructured":"Kassem M, Brixen K, Blum WF, Mosekilde L, Eriksen EF. Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis. J. Bone Miner Res 1994;9:1365\u201370.","journal-title":"J. Bone Miner Res"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/BF01622196","volume":"4","author":"C Hassager","year":"1994","unstructured":"Hassager C, Risteli J, Christiansen C. Effect of the menopause and hormone replacement therapy on the carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen. Osteoporosis Int 1994;4:349\u201352.","journal-title":"Osteoporosis Int"},{"key":"CR26","first-page":"1693","volume":"79","author":"P Garnero","year":"1994","unstructured":"Garnero P, Shih WJ, Gineyts E, Karpf DB, Delmas PD. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J Clin Endocrinol Metab 1994;79:1693\u2013700.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR27","first-page":"780","volume":"79","author":"P Garnero","year":"1994","unstructured":"Garnero P, Gineyts E, Riou JP, Delmas PD. Assessment of bone resporption with a new marker of collagen degradation in patients with metabolic bone disease. J Clin Endocrinol Metab 1994;79:780\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jbmr.5650100418","volume":"10","author":"P Garnero","year":"1995","unstructured":"Garnero P, Gyneyts E, Arbault P, Christiansen C, Delmas PD. Different effects of bisphosphonate and estrogen therapy on free and peptide-bound bone cross-links excretion. J Bone Miner Res 1995;10:641\u20139.","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01623388.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01623388\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01623388","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T01:00:26Z","timestamp":1735693226000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01623388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1996,7]]}},"alternative-id":["BF01623388"],"URL":"https:\/\/doi.org\/10.1007\/bf01623388","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[1996,7]]}}}